AI × HEALTH
Better tools.
Human care.
Discover what health AI does. And where it fits.Explore the world ↓Product discovery, not medical advice. Clinical tools require the right care setting and local authorisation.
THE GLOBAL PICTURE
Find the right role.
6 projects · countries describe the example or provider location, not worldwide availability.
GermanySymptom guidance
Understand your symptoms.
AdaExplore possible causes and next steps.
- Symptoms
- Questions
- Care guidance
- FOR
- Individuals
- ACCESS
- Consumer app · check local availability
Who uses it? Cost & evidence +
Documented exampleGerman provider; consumer symptom guidance.
AdoptionIndividual user count not verified.
Cost routeCheck app terms. Verify with the provider.
Important limitNot a diagnosis or replacement for medical advice.
Source · Undated documentation ↗Additional source ↗Source checked 2026-11-06. Examples are not an effectiveness ranking or a current global user count. United StatesClinical notes
Conversation → clinical notes.
AbridgeDraft structured notes from clinical conversations.
- Conversation
- Draft note
- Clinician review
- FOR
- Clinical teams
- ACCESS
- Health-system deployment
Who uses it? Cost & evidence +
Documented exampleUNC Health announced expansion after its pilot.
Adoption100 clinicians in a UNC pilot · not total users.
Cost routeRequest provider quote. Verify with the provider.
Important limitClinical teams must review documentation and follow consent policies.
Source · 4 February 2025 · historical deployment report ↗Additional source ↗Source checked 2026-11-06. Examples are not an effectiveness ranking or a current global user count. IndiaMedical imaging
X-rays. Another layer of insight.
Qure.ai · qXRSupport chest X-ray screening and triage.
- Chest X-ray
- AI findings
- Clinical follow-up
- FOR
- Screening programmes
- ACCESS
- Clinical programme integration
Who uses it? Cost & evidence +
Documented exampleVendor reported a PATH India collaboration in Maharashtra.
AdoptionCurrent user count not verified.
Cost routeRequest provider quote. Verify with the provider.
Important limitScreening findings may require confirmatory testing; not a consumer diagnosis.
Source · 14 September 2023 · historical programme report ↗Additional source ↗Source checked 2026-11-06. Examples are not an effectiveness ranking or a current global user count. United KingdomSkin assessment
Skin images → a care pathway.
Skin Analytics · DERMAssess dermoscopic images in skin-lesion referral pathways.
- Clinical image
- AI assessment
- Pathway decision
- FOR
- Dermatology services
- ACCESS
- Participating clinical pathways
Who uses it? Cost & evidence +
Documented exampleChelsea and Westminster appears in the provider’s deployment list.
AdoptionProvider lists NHS deployments; no current user total verified.
Cost routeProvider procurement. Verify with the provider.
Important limitEligibility and clinical review depend on the local pathway; not a general photo diagnosis.
Source · Rolling provider documentation ↗Additional source ↗Source checked 2026-11-06. Examples are not an effectiveness ranking or a current global user count. AustraliaMedical imaging
Help radiologists inspect scans.
Annalise.aiSupport radiologists reviewing chest X-rays.
- Chest X-ray
- Decision support
- Radiologist report
- FOR
- Radiology teams
- ACCESS
- Institutional use · regional terms vary
Who uses it? Cost & evidence +
Documented exampleRoyal Brisbane and Women’s Hospital described radiologists retaining final reporting responsibility.
AdoptionRBWH trial reported in August 2025.
Cost routeRequest provider quote. Verify with the provider.
Important limitThe hospital report describes a trial, not a proven speed benefit or current rollout.
Source · 25 August 2025 · historical trial ↗Source checked 2026-11-06. Examples are not an effectiveness ranking or a current global user count. SwedenMedical imaging
AI alongside breast screening.
Lunit INSIGHT MMGSupport interpretation of screening mammograms.
- Mammogram
- AI analysis
- Screening workflow
- FOR
- Screening radiologists
- ACCESS
- Clinical screening programmes
Who uses it? Cost & evidence +
Documented exampleSouth Korean developer; this example concerns use in Sweden.
AdoptionUse at Capio St. Göran described by Karolinska Institutet.
Cost routeRequest provider quote. Verify with the provider.
Important limitEvidence and deployment are specific to the product, population and programme.
Source · 10 June 2026 · research institution report ↗Additional source ↗Source checked 2026-11-06. Examples are not an effectiveness ranking or a current global user count.